Hamilton Thomas Edward 4
4 · Larimar Therapeutics, Inc. · Filed Jul 2, 2021
Insider Transaction Report
Form 4
Hamilton Thomas Edward
Director
Transactions
- Purchase
Common Stock
2021-06-30$8.75/sh+56,710$496,213→ 190,130 total
Holdings
- 159,433(indirect: FA Life Sciences, Inc.)
Common Stock